tetano
Editor, Senior Moderator
Cureus
. 2022 Jun 14;14(6):e25937.
doi: 10.7759/cureus.25937. eCollection 2022 Jun.
Long-Term Symptoms of COVID-19: One-Year Follow-Up Study
Fnu Shivani[SUP] 1 [/SUP], Naina Kumari[SUP] 2 [/SUP], Pinky Bai[SUP] 3 [/SUP], Fnu Rakesh[SUP] 3 [/SUP], Muhammad Haseeb[SUP] 4 [/SUP], Sunny Kumar[SUP] 5 [/SUP], Amna Jamil[SUP] 6 [/SUP], Maheen Zaidi[SUP] 3 [/SUP], Faizan Shaukat[SUP] 2 [/SUP], Amber Rizwan[SUP] 7 [/SUP]
Affiliations
Abstract
Introduction: Persistent and prolonged symptoms, termed as long COVID (coronavirus disease), have been reported in several patients who recovered from the acute phase at different intervals. However, there has been largely unclear data regarding the full range of long-term sequelae of coronavirus disease 2019 (COVID-19) patients. This study aims to evaluate the prevalence of long COVID syndrome.
Methods: A long-term research was conducted in the COVID-19 unit of a tertiary care hospital in Pakistan from July 2020 to December 2021 in which 2,000 patients who had recovered from COVID-19 and had been discharged were included in the study. Symptoms were noted at the time of discharge and at follow-up after 12 months. Data were analyzed using Statistical Package for the Social Sciences (SPSS) v. 22.0 (IBM Corporation, Armonk, New York, United States).
Results: The mean age of the participants was 43 ± 10 years, 801 (53.8%) males and 688 (46.2%) females. At the time of discharge, the most common symptom was fatigue (26.93%), followed by dyspnea (20.34%) and muscle pain (8.86%). The most common symptom on follow-up was fatigue (6.78%).
Conclusion: We strongly emphasize discussing and exploring further knowledge on the post-infection syndrome, with an aim to bring healthcare professionals' attention to the importance of handling COVID patients, their counseling, warning for alarming signs, and a long-term follow-up with necessary investigations and treatment.
Keywords: covid-19; long-covid-19; multisystem; pneumonia; sars-cov-2 (severe acute respiratory syndrome coronavirus -2).
. 2022 Jun 14;14(6):e25937.
doi: 10.7759/cureus.25937. eCollection 2022 Jun.
Long-Term Symptoms of COVID-19: One-Year Follow-Up Study
Fnu Shivani[SUP] 1 [/SUP], Naina Kumari[SUP] 2 [/SUP], Pinky Bai[SUP] 3 [/SUP], Fnu Rakesh[SUP] 3 [/SUP], Muhammad Haseeb[SUP] 4 [/SUP], Sunny Kumar[SUP] 5 [/SUP], Amna Jamil[SUP] 6 [/SUP], Maheen Zaidi[SUP] 3 [/SUP], Faizan Shaukat[SUP] 2 [/SUP], Amber Rizwan[SUP] 7 [/SUP]
Affiliations
- PMID: 35844318
- PMCID: PMC9282616
- DOI: 10.7759/cureus.25937
Abstract
Introduction: Persistent and prolonged symptoms, termed as long COVID (coronavirus disease), have been reported in several patients who recovered from the acute phase at different intervals. However, there has been largely unclear data regarding the full range of long-term sequelae of coronavirus disease 2019 (COVID-19) patients. This study aims to evaluate the prevalence of long COVID syndrome.
Methods: A long-term research was conducted in the COVID-19 unit of a tertiary care hospital in Pakistan from July 2020 to December 2021 in which 2,000 patients who had recovered from COVID-19 and had been discharged were included in the study. Symptoms were noted at the time of discharge and at follow-up after 12 months. Data were analyzed using Statistical Package for the Social Sciences (SPSS) v. 22.0 (IBM Corporation, Armonk, New York, United States).
Results: The mean age of the participants was 43 ± 10 years, 801 (53.8%) males and 688 (46.2%) females. At the time of discharge, the most common symptom was fatigue (26.93%), followed by dyspnea (20.34%) and muscle pain (8.86%). The most common symptom on follow-up was fatigue (6.78%).
Conclusion: We strongly emphasize discussing and exploring further knowledge on the post-infection syndrome, with an aim to bring healthcare professionals' attention to the importance of handling COVID patients, their counseling, warning for alarming signs, and a long-term follow-up with necessary investigations and treatment.
Keywords: covid-19; long-covid-19; multisystem; pneumonia; sars-cov-2 (severe acute respiratory syndrome coronavirus -2).